'Drug Factory' Implants Target Cancer Cells

Tiny implants being developed at Rice University activate immune cells that destroy cancer.

“In this study, we demonstrated that the ‘drug factories’ allow regulatable local administration of interleukin-2 and eradication of tumor in several mouse models, which is very exciting. This provides a strong rationale for clinical testing,” said study co-author Dr. Amir Jazaeri , professor of gynecologic oncology and reproductive medicine at MD Anderson.